Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial

Hepatitis C virus genotype 2 (HCV-2) slow responders poorly respond to 24 weeks of peginterferon (Peg-IFN) plus ribavirin (RBV). We evaluated the efficacy of extended 48-week regimen and the role of interleukin-28B (IL-28B) genotype in this clinical setting. Treatment-naïve HCV-2 patients not achiev...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chen-Hua, Huang, Chung-Feng, Liu, Chun-Jen, Dai, Chia-Yen, Huang, Jee-Fu, Lin, Jou-Wei, Liang, Cheng-Chao, Yang, Sheng-Shun, Lin, Chih-Lin, Su, Tung-Hung, Yang, Hung-Chih, Chen, Pei-Jer, Chen, Ding-Shinn, Chuang, Wan-Long, Kao, Jia-Horng, Yu, Ming-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486927/
https://www.ncbi.nlm.nih.gov/pubmed/26130141
http://dx.doi.org/10.1038/srep11710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486927/
https://www.ncbi.nlm.nih.gov/pubmed/26130141
http://dx.doi.org/10.1038/srep11710

Ejemplares similares